We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+12.52%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.98B
AUM Growth
+$200M
Cap. Flow
-$63.9M
Cap. Flow %
-2.15%
Top 10 Hldgs %
26.81%
Holding
372
New
42
Increased
59
Reduced
133
Closed
37

Top Buys

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$27.8M
2
UNP icon
Union Pacific
UNP
+$22.7M
3
EW icon
Edwards Lifesciences
EW
+$19.3M
4
SCHW
Charles Schwab
SCHW
+$13.8M
5
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$13.7M

Top Sells

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$33.6M
2
KSU
Kansas City Southern
KSU
+$26M
3
NOW icon
ServiceNow
NOW
+$24.6M
4
HCA icon
HCA Healthcare
HCA
+$13.9M
5
DAR icon
Darling Ingredients
DAR
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 27.56%
2 Consumer Discretionary 17.07%
3 Healthcare 15.76%
4 Financials 10.85%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPR icon
101
Tapestry
TPR
$29.9B
$8.05M 0.27%
185,080
-108,255
-37% -$4.83M
TGTX icon
102
TG Therapeutics
TGTX
$8.15B
$8.02M 0.27%
206,761
-10,870
-5% -$427K
NVEE
103
DELISTED
NV5 Global
NVEE
$7.97M 0.27%
337,308
-8,320
-2% -$189K
ACHC icon
104
Acadia Healthcare
ACHC
$2.55B
$7.83M 0.26%
124,860
+56,615
+83% +$3.55M
AVYA
105
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$7.74M 0.26%
287,874
-150,550
-34% -$4.23M
MPLX icon
106
MPLX
MPLX
$60.4B
$7.7M 0.26%
260,042
– –
NARI
107
DELISTED
Inari Medical, Inc. Common Stock
NARI
$7.67M 0.26%
82,190
+45,670
+125% +$4.43M
SWTX
108
DELISTED
SpringWorks Therapeutics
SWTX
$7.56M 0.25%
91,686
-2,270
-2% -$172K
CRNC icon
109
Cerence
CRNC
$356M
$7.53M 0.25%
70,566
-33,905
-32% -$3.34M
DY icon
110
Dycom Industries
DY
$11.4B
$7.44M 0.25%
99,873
-5,440
-5% -$469K
PLBY icon
111
Playboy Inc
PLBY
$138M
$7.38M 0.25%
+189,810
New +$7.99M
AXNX
112
DELISTED
Axonics, Inc. Common Stock
AXNX
$7.14M 0.24%
112,582
+25,665
+30% +$1.52M
SYNA icon
113
Synaptics
SYNA
$4.14B
$7.11M 0.24%
45,690
-3,310
-7% -$447K
KEX icon
114
Kirby Corp
KEX
$7.16B
$6.99M 0.23%
115,340
+25,400
+28% +$1.64M
ATEC icon
115
Alphatec Holdings
ATEC
$1.45B
$6.97M 0.23%
454,725
-11,230
-2% -$173K
SIBN icon
116
SI-BONE Inc
SIBN
$807M
$6.96M 0.23%
221,285
+133,460
+152% +$4.32M
NGVT icon
117
Ingevity
NGVT
$2.5B
$6.94M 0.23%
+85,280
New +$6.86M
UCTT
118
Ultra Clean Holdings
UCTT
$3.2B
$6.92M 0.23%
+128,849
New +$6.9M
SLB icon
119
SLB Ltd
SLB
$73.4B
$6.58M 0.22%
+205,700
New +$6.32M
ARWR icon
120
Arrowhead Research
ARWR
$12.1B
$6.43M 0.22%
77,700
+10,535
+16% +$784K
ET icon
121
Energy Transfer Partners
ET
$70.2B
$6.42M 0.22%
603,890
+48,240
+9% +$462K
UAA icon
122
Under Armour
UAA
$2.95B
$6.33M 0.21%
299,310
-190,285
-39% -$4.24M
VYX icon
123
NCR Voyix
VYX
$1.18B
$6.32M 0.21%
+225,731
New +$6.25M
DAN icon
124
Dana Inc
DAN
$2.89B
$6.17M 0.21%
259,598
-27,632
-10% -$716K
WW
125
DELISTED
WW International
WW
$6.11M 0.21%
+169,155
New +$5.8M
3 4
5
6 7

Similar funds

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return

Castleark Management's Q2 2021 Portfolio in Review

As of Q2 2021, Castleark Management held 372 positions worth $2.98B, up 7.2% from $2.78B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Castleark Management's Q2 2021 filing shows 42 new, 59 increased, 133 reduced and 37 closed positions. Its largest new stake was Ulta Beauty: 84,780 shares worth $29.3M. The largest sale was Canadian Pacific Kansas City, an estimated $33.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Castleark Management's largest Q2 2021 buy was Ulta Beauty: 84,780 shares worth $29.3M.
  • Castleark Management added most to Edwards Lifesciences in Q2 2021, an estimated $19.3M increase.
  • Castleark Management's biggest Q2 2021 reduction was HCA Healthcare, cutting an estimated $13.9M.
  • Castleark Management fully exited Canadian Pacific Kansas City in Q2 2021, selling an estimated $33.6M.
  • Castleark Management's ten largest holdings make up 27% of its $2.98B portfolio in Q2 2021.
  • Castleark Management opened 42 new positions and closed 37 in Q2 2021.
  • Castleark Management's portfolio value rose 7.2% quarter-over-quarter to $2.98B.

Based on Castleark Management's 13F filing for Q2 2021, filed 17 Aug 2021.